JPMorgan Chase & Co’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $117M | Sell |
|
|||||
|
2025
Q2 | $104M | Sell |
|
|||||
|
2025
Q1 | $131M | Sell |
|
|||||
|
2024
Q4 | $167M | Sell |
|
|||||
|
2024
Q3 | $188M | Buy |
|
|||||
|
2024
Q2 | $121M | Sell |
|
|||||
|
2024
Q1 | $113M | Sell |
|
|||||
|
2023
Q4 | $126M | Buy |
|
|||||
|
2023
Q3 | $118M | Buy |
|
|||||
|
2023
Q2 | $106M | Buy |
|
|||||
|
2023
Q1 | $70.7M | Buy |
|
|||||
|
2022
Q4 | $61.8M | Buy |
|
|||||
|
2022
Q3 | $35.3M | Sell |
|
|||||
|
2022
Q2 | $36.1M | Buy |
|
|||||
|
2022
Q1 | $34.2M | Buy |
|
|||||
|
2021
Q4 | $32.3M | Sell |
|
|||||
|
2021
Q3 | $36.3M | Sell |
|
|||||
|
2021
Q2 | $44M | Buy |
|
|||||
|
2021
Q1 | $56.7M | Buy |
|
|||||
|
2020
Q4 | $45.9M | Buy |
|
|||||
|
2020
Q3 | $37.7M | Buy |
|
|||||
|
2020
Q2 | $24.4M | Buy |
|
|||||
|
2020
Q1 | $11.2M | Buy |
|